Sarah Fidler

Sarah Fidler is an immunologist, researcher and professor in HIV Medicine at Imperial College London and consultant physician in HIV for St Mary's Hospital, London.

Her clinical work involves looking after people who have just been infected with the human immunodeficiency virus (HIV), and testing new approaches towards curing HIV. Provided by Wikipedia
Showing 1 - 20 results of 26 for search 'Sarah Fidler', query time: 0.02s Refine Results
  1. 1
    Uptake of home-based voluntary HIV testing in sub-Saharan Africa: a systematic review and meta-analysis.

    Uptake of home-based voluntary HIV testing in sub-Saharan Africa: a systematic review and meta-analysis. by Kalpana Sabapathy, Rafael Van den Bergh, Sarah Fidler, Richard Hayes, Nathan Ford

    Published 2012-01-01
    Get full text
    Article
    Save to List
    Saved in:
  2. 2
    Evaluation of the effect of 48 weeks of BIC/F/TAF and DRV/c/F/TAF on platelet function in the context of rapid ART start

    Evaluation of the effect of 48 weeks of BIC/F/TAF and DRV/c/F/TAF on platelet function in the context of rapid ART start by Akif A. Khawaja, Gary Whitlock, Sarah Fidler, Alfredo Soler-Carracedo, Merle Henderson, Graham P. Taylor, Marta Boffito, Michael Emerson

    Published 2025-12-01
    Get full text
    Article
    Save to List
    Saved in:
  3. 3
    HIV treatment-as-prevention research: taking the right road at the crossroads.

    HIV treatment-as-prevention research: taking the right road at the crossroads. by Richard Hayes, Sarah Fidler, Anne Cori, Christophe Fraser, Sian Floyd, Helen Ayles, Nulda Beyers, Wafaa El-Sadr, HPTN 071 (PopART) Study Team

    Published 2015-03-01
    Get full text
    Article
    Save to List
    Saved in:
  4. 4
    Histone Deacetylase Inhibitors Enhance CD4 T Cell Susceptibility to NK Cell Killing but Reduce NK Cell Function.

    Histone Deacetylase Inhibitors Enhance CD4 T Cell Susceptibility to NK Cell Killing but Reduce NK Cell Function. by Matthew Pace, James Williams, Ayako Kurioka, Andrew B Gerry, Bent Jakobsen, Paul Klenerman, Nneka Nwokolo, Julie Fox, Sarah Fidler, John Frater, CHERUB Investigators

    Published 2016-08-01
    Get full text
    Article
    Save to List
    Saved in:
  5. 5
    Acceptability of and experiences with menstrual hygiene cups among adolescent girls and young women aged 15–24 in two communities in Lusaka, Zambia: an exploratory study nested in the Yathu Yathu trial

    Acceptability of and experiences with menstrual hygiene cups among adolescent girls and young women aged 15–24 in two communities in Lusaka, Zambia: an exploratory study nested in... by Melleh Gondwe, Melvin Simuyaba, Mwelwa Phiri, Chisanga Mwansa, Albertus Schaap, Lucheka Sigande, Kwame Shanaube, Sian Floyd, Sarah Fidler, Helen Ayles, Musonda Simwinga, Bernadette Hensen

    Published 2025-02-01
    Get full text
    Article
    Save to List
    Saved in:
  6. 6
    Depressive symptoms and HIV risk behaviours among adolescents enrolled in the HPTN071 (PopART) trial in Zambia and South Africa.

    Depressive symptoms and HIV risk behaviours among adolescents enrolled in the HPTN071 (PopART) trial in Zambia and South Africa. by Kwame Shanaube, Thomas Gachie, Graeme Hoddinott, Albertus Schaap, Sian Floyd, Tila Mainga, Virginia Bond, Richard Hayes, Sarah Fidler, Helen Ayles, HPTN071 (PopART) Study Team

    Published 2022-01-01
    Get full text
    Article
    Save to List
    Saved in:
  7. 7
    A randomised control trial of BIC/F/TAF vs DRV/c/F/TAF in context of HIV test-and-treat, BicTnT

    A randomised control trial of BIC/F/TAF vs DRV/c/F/TAF in context of HIV test-and-treat, BicTnT by Gary Whitlock, Sarah Fidler, Amanda Clarke, Sujin Kang, Arnold Xhikola, Ana Milinkovic, Alfredo Soler-Carracedo, Merle Henderson, Tanya Adams, Ishrat Jahan, Akif Khawaja, Graham Taylor, Marta Boffito

    Published 2024-12-01
    Get full text
    Article
    Save to List
    Saved in:
  8. 8
    The impact of community-based, peer-led sexual and reproductive health services on knowledge of HIV status among adolescents and young people aged 15 to 24 in Lusaka, Zambia: The Yathu Yathu cluster-randomised trial.

    The impact of community-based, peer-led sexual and reproductive health services on knowledge of HIV status among adolescents and young people aged 15 to 24 in Lusaka, Zambia: The Y... by Bernadette Hensen, Sian Floyd, Mwelwa M Phiri, Ab Schaap, Lucheka Sigande, Melvin Simuyaba, Lawrence Mwenge, Rosemary Zulu-Phiri, Louis Mwape, Sarah Fidler, Richard Hayes, Musonda Simwinga, Helen Ayles

    Published 2023-04-01
    Get full text
    Article
    Save to List
    Saved in:
  9. 9
    Duration of HIV-1 viral suppression on cessation of antiretroviral therapy in primary infection correlates with time on therapy.

    Duration of HIV-1 viral suppression on cessation of antiretroviral therapy in primary infection correlates with time on therapy. by Wolfgang Stöhr, Sarah Fidler, Myra McClure, Jonathan Weber, David Cooper, Gita Ramjee, Pontiano Kaleebu, Giuseppe Tambussi, Mauro Schechter, Abdel Babiker, Rodney E Phillips, Kholoud Porter, John Frater

    Published 2013-01-01
    Get full text
    Article
    Save to List
    Saved in:
  10. 10
    Clinical outcomes of participants of a TB prevalence survey with an abnormal chest X-ray but no evidence of TB disease after a median follow-up of 9 months in Zambia and South Africa

    Clinical outcomes of participants of a TB prevalence survey with an abnormal chest X-ray but no evidence of TB disease after a median follow-up of 9 months in Zambia and South Afri... by Maria Ruperez, Jacob Busang, Linda Mureithi, Kwame Shanaube, Eveline Klinkenberg, Thomas Gachie, James M. Burnett, Barry Kosloff, Petra de Haas, Richard Hayes, Sarah Fidler, Ab Schaap, Sian Floyd, Helen Ayles

    Published 2025-01-01
    Get full text
    Article
    Save to List
    Saved in:
  11. 11
    Role of HIV infection duration and CD4 cell level at initiation of combination anti-retroviral therapy on risk of failure.

    Role of HIV infection duration and CD4 cell level at initiation of combination anti-retroviral therapy on risk of failure. by Sara Lodi, Andrew Phillips, Sarah Fidler, David Hawkins, Richard Gilson, Ken McLean, Martin Fisher, Frank Post, Anne M Johnson, Louise Walker-Nthenda, David Dunn, Kholoud Porter, UK Register of HIV

    Published 2013-01-01
    Get full text
    Article
    Save to List
    Saved in:
  12. 12
    The Impact of HCV Infection Duration on HIV Disease Progression and Response to cART amongst HIV Seroconverters in the UK.

    The Impact of HCV Infection Duration on HIV Disease Progression and Response to cART amongst HIV Seroconverters in the UK. by Jamie Inshaw, Clifford Leen, Martin Fisher, Richard Gilson, David Hawkins, Simon Collins, Julie Fox, Ken McLean, Sarah Fidler, Andrew Phillips, Sam Lattimore, Abdel Babiker, Kholoud Porter, UK HIV Seroconverters Cohort

    Published 2015-01-01
    Get full text
    Article
    Save to List
    Saved in:
  13. 13
    Factors associated with use of community-based, peer-led sexual and reproductive health services by adolescent boys and young men aged 18-24 in Lusaka, Zambia: A case control study nested in the Yathu Yathu trial.

    Factors associated with use of community-based, peer-led sexual and reproductive health services by adolescent boys and young men aged 18-24 in Lusaka, Zambia: A case control study... by Mwelwa M Phiri, Bernadette Hensen, Lucheka M Sigande, Sian Floyd, Albertus J Schaap, Melvin Simuyaba, Lawrence Mwenge, Rosemary Zulu-Phiri, Louis Mwape, Sarah Fidler, Musonda Simwinga, Richard Hayes, Helen M Ayles

    Published 2023-01-01
    Get full text
    Article
    Save to List
    Saved in:
  14. 14
    Structured observations reveal slow HIV-1 CTL escape.

    Structured observations reveal slow HIV-1 CTL escape. by Hannah E Roberts, Jacob Hurst, Nicola Robinson, Helen Brown, Peter Flanagan, Laura Vass, Sarah Fidler, Jonathan Weber, Abdel Babiker, Rodney E Phillips, Angela R McLean, John Frater, SPARTAC trial investigators

    Published 2015-02-01
    Get full text
    Article
    Save to List
    Saved in:
  15. 15
    Plasma HIV viral rebound following protocol-indicated cessation of ART commenced in primary and chronic HIV infection.

    Plasma HIV viral rebound following protocol-indicated cessation of ART commenced in primary and chronic HIV infection. by Elizabeth Hamlyn, Fiona M Ewings, Kholoud Porter, David A Cooper, Giuseppe Tambussi, Mauro Schechter, Court Pedersen, Jason F Okulicz, Myra McClure, Abdel Babiker, Jonathan Weber, Sarah Fidler, INSIGHT SMART and SPARTAC Investigators

    Published 2012-01-01
    Get full text
    Article
    Save to List
    Saved in:
  16. 16
    Clinical outcomes of participants of a TB prevalence survey with an abnormal chest X-ray but no evidence of TB disease after a median follow-up of 9 months in Zambia and South Africa.

    Clinical outcomes of participants of a TB prevalence survey with an abnormal chest X-ray but no evidence of TB disease after a median follow-up of 9 months in Zambia and South Afri... by Maria Ruperez, Jacob Busang, Linda Mureithi, Kwame Shanaube, Eveline Klinkenberg, Thomas Gachie, James M Burnett, Barry Kosloff, Petra de Haas, Richard Hayes, Sarah Fidler, Ab Schaap, Sian Floyd, Helen Ayles, TREATS study team

    Published 2025-01-01
    Get full text
    Article
    Save to List
    Saved in:
  17. 17
    A universal testing and treatment intervention to improve HIV control: One-year results from intervention communities in Zambia in the HPTN 071 (PopART) cluster-randomised trial.

    A universal testing and treatment intervention to improve HIV control: One-year results from intervention communities in Zambia in the HPTN 071 (PopART) cluster-randomised trial. by Richard Hayes, Sian Floyd, Ab Schaap, Kwame Shanaube, Peter Bock, Kalpana Sabapathy, Sam Griffith, Deborah Donnell, Estelle Piwowar-Manning, Wafaa El-Sadr, Nulda Beyers, Helen Ayles, Sarah Fidler, HPTN 071 (PopART) Study Team

    Published 2017-05-01
    Get full text
    Article
    Save to List
    Saved in:
  18. 18
    Enhanced immune responses following heterologous vaccination with self-amplifying RNA and mRNA COVID-19 vaccines.

    Enhanced immune responses following heterologous vaccination with self-amplifying RNA and mRNA COVID-19 vaccines. by Tamara Elliott, Hannah M Cheeseman, Abbey B Evans, Suzanne Day, Leon R McFarlane, Jessica O'Hara, Mohini Kalyan, Fahimah Amini, Tom Cole, Alan Winston, Sarah Fidler, Katrina M Pollock, James A Harker, Robin J Shattock

    Published 2022-10-01
    Get full text
    Article
    Save to List
    Saved in:
  19. 19
    PopART-IBM, a highly efficient stochastic individual-based simulation model of generalised HIV epidemics developed in the context of the HPTN 071 (PopART) trial.

    PopART-IBM, a highly efficient stochastic individual-based simulation model of generalised HIV epidemics developed in the context of the HPTN 071 (PopART) trial. by Michael Pickles, Anne Cori, William J M Probert, Rafael Sauter, Robert Hinch, Sarah Fidler, Helen Ayles, Peter Bock, Deborah Donnell, Ethan Wilson, Estelle Piwowar-Manning, Sian Floyd, Richard J Hayes, Christophe Fraser, HPTN 071 (PopART) Study Team

    Published 2021-09-01
    Get full text
    Article
    Save to List
    Saved in:
  20. 20
    Exhaustion of Activated CD8 T Cells Predicts Disease Progression in Primary HIV-1 Infection.

    Exhaustion of Activated CD8 T Cells Predicts Disease Progression in Primary HIV-1 Infection. by Matthias Hoffmann, Nikos Pantazis, Genevieve E Martin, Stephen Hickling, Jacob Hurst, Jodi Meyerowitz, Christian B Willberg, Nicola Robinson, Helen Brown, Martin Fisher, Sabine Kinloch, Abdel Babiker, Jonathan Weber, Nneka Nwokolo, Julie Fox, Sarah Fidler, Rodney Phillips, John Frater, SPARTAC and CHERUB Investigators

    Published 2016-07-01
    Get full text
    Article
    Save to List
    Saved in:

Search Tools: